13F

RNAC CARTESIAN THERAPEUTICS INC

2026Q1 · CUSIP 816212302 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
82
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
45
Δ whales
+5
Inst. holding value
$44M
New positions
28
Closed positions
13
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2023Q2: Δ+0 · h=1 2023Q3: Δ+0 · h=1 2024Q1: Δ+3 · h=4 2024Q2: Δ+57 · h=61 2024Q3: Δ+5 · h=66 2024Q4: Δ+2 · h=68 2025Q1: Δ+5 · h=73 2025Q2: Δ-6 · h=67 2025Q3: Δ+1 · h=68 2025Q4: Δ-1 · h=67 2026Q1: Δ+15 · h=82 2023Q2: holders=1 2023Q3: holders=1 2024Q1: holders=4 2024Q2: holders=61 2024Q3: holders=66 2024Q4: holders=68 2025Q1: holders=73 2025Q2: holders=67 2025Q3: holders=68 2025Q4: holders=67 2026Q1: holders=82 -57 -28.5 +0 +28.5 +57 04487 23Q223Q324Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 2%

Options Sentiment

Put holders
0
QoQ: -2
Call holders
0
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-5.80
EPS YoY
-208.8%
Revenue (TTM)
$0.0B
Revenue YoY
-94.8%
Quarterly Revenue & EPS (4Y)
2023-06-30: $5M 2023-09-30: $7M 2024-03-31: $6M 2024-06-30: $33M 2024-09-30: $0M 2024-12-31: $-1M 2025-03-31: $1M 2025-06-30: $0M 2025-09-30: $0M 2025-12-31: $1M 2026-03-31: $0M 2024-06-30: EPS 0.54 2024-09-30: EPS -1.13 2025-03-31: EPS -0.68 2025-06-30: EPS 0.50 2025-09-30: EPS -1.38 2025-12-31: EPS -3.46 2026-03-31: EPS -1.46 0M 17M 33M $M -3.81 -1.61 0.59 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)